BE905790A - Peptide de venin de serpent arretant la croissance. - Google Patents

Peptide de venin de serpent arretant la croissance.

Info

Publication number
BE905790A
BE905790A BE0/217441A BE217441A BE905790A BE 905790 A BE905790 A BE 905790A BE 0/217441 A BE0/217441 A BE 0/217441A BE 217441 A BE217441 A BE 217441A BE 905790 A BE905790 A BE 905790A
Authority
BE
Belgium
Prior art keywords
snake venom
venom peptide
stopping growth
growth
stopping
Prior art date
Application number
BE0/217441A
Other languages
English (en)
Original Assignee
Oncogen Soc En Commandite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen Soc En Commandite filed Critical Oncogen Soc En Commandite
Publication of BE905790A publication Critical patent/BE905790A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

De nouveaux agents cytotoxiques sont obtenus sous forme de courts polypeptides correspondant à un peptide à faible poids moléculaire dérivé du Crotalus atrox. Les composés peuvent etre utilisés seuls ou en combinaison avec d'autres réactifs, tels des anticorps, pour inhiber la croissance des cellules.
BE0/217441A 1985-11-22 1986-11-19 Peptide de venin de serpent arretant la croissance. BE905790A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/801,019 US4731439A (en) 1985-11-22 1985-11-22 Snake venom growth arresting peptide

Publications (1)

Publication Number Publication Date
BE905790A true BE905790A (fr) 1987-05-19

Family

ID=25179974

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217441A BE905790A (fr) 1985-11-22 1986-11-19 Peptide de venin de serpent arretant la croissance.

Country Status (20)

Country Link
US (1) US4731439A (fr)
KR (1) KR900006575B1 (fr)
CN (1) CN86108593A (fr)
AU (3) AU6556386A (fr)
BE (1) BE905790A (fr)
CH (1) CH670451A5 (fr)
DE (1) DE3639796A1 (fr)
DK (1) DK560986A (fr)
ES (1) ES2002915A6 (fr)
FI (1) FI864715A7 (fr)
FR (1) FR2590576A1 (fr)
GB (1) GB2185023B (fr)
GR (1) GR862788B (fr)
IT (1) IT1207580B (fr)
LU (1) LU86683A1 (fr)
NL (1) NL8602939A (fr)
PT (1) PT83790B (fr)
SE (1) SE8604991L (fr)
YU (1) YU199586A (fr)
ZA (1) ZA868849B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015072A1 (fr) * 1989-06-07 1990-12-13 Genentech, Inc. Inhibiteurs d'agregation de thrombocytes et molecules associees
WO1991001740A1 (fr) * 1989-08-05 1991-02-21 Varánusz Gm Procede de production de pharmacosmetiques
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
ATE157672T1 (de) * 1992-07-27 1997-09-15 Pfizer Calcium-kanal blockierende polypeptide aus agelenopsis aperta
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
SG129211A1 (en) * 1997-11-06 2007-02-26 Univ Singapore Therapeutic molecules
BR0101088A (pt) * 2001-03-19 2003-03-18 Biolab Sanus Farmaceutica Ltda Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
BRPI0501037B8 (pt) * 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
US20060234934A1 (en) * 2005-04-15 2006-10-19 Kilmon Joseph A Composition and Method for Selective Cytostasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4220722A (en) * 1978-02-10 1980-09-02 Syva Company Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
US4500637A (en) * 1982-07-19 1985-02-19 The United States Of America As Represented By The Department Of Health And Human Services Prevention of graft versus host disease following bone marrow transplantation

Also Published As

Publication number Publication date
GB8627710D0 (en) 1986-12-17
GB2185023A (en) 1987-07-08
IT8622425A0 (it) 1986-11-21
YU199586A (en) 1988-06-30
FI864715A0 (fi) 1986-11-19
CH670451A5 (fr) 1989-06-15
FI864715A7 (fi) 1987-05-23
ES2002915A6 (es) 1988-10-01
CN86108593A (zh) 1987-09-30
PT83790B (pt) 1989-09-14
ZA868849B (en) 1987-07-29
AU6556386A (en) 1987-05-28
KR870005014A (ko) 1987-06-04
SE8604991L (sv) 1987-05-23
US4731439A (en) 1988-03-15
PT83790A (en) 1986-12-01
FR2590576A1 (fr) 1987-05-29
GB2185023B (en) 1990-08-29
AU6560986A (en) 1987-05-28
AU6667590A (en) 1991-03-28
SE8604991D0 (sv) 1986-11-21
DE3639796A1 (de) 1987-07-09
KR900006575B1 (ko) 1990-09-13
GR862788B (en) 1987-03-26
DK560986D0 (da) 1986-11-21
DK560986A (da) 1987-05-23
IT1207580B (it) 1989-05-25
LU86683A1 (fr) 1987-06-26
NL8602939A (nl) 1987-06-16

Similar Documents

Publication Publication Date Title
EP0783299A4 (fr) Composes et compositions pour l'administration d'agents actifs
BG94804A (bg) Изолати от триходерма,фунгицидни състави,съдържащи тези изолати,и използването им срещу в.сinеrеа и s.sсlеrотiоruм
OA09850A (fr) Conjugués d'interféron et composés les contenant.
CA2246289A1 (fr) Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
LU90312I2 (fr) S-N-éthyl-3-[(1-diméthyl-amino)éthyl]-N-méthyl-phénylcarbamate ou un sel pharmaceutiquement acceptable de celui-ci en particulier le tartrate hydrogène
CA2090614A1 (fr) Mutations d'adn-polymerases thermostables par une exonuclease de 5' a 3'
FR2445348A1 (fr) Copolymeres isomorphes d'epsilon-caprolactone et de 1,5-dioxepan-2-one et filaments prepares avec ces copolymeres
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
EP0670735A1 (fr) Peripherisation de cellules souches hematopoietiques.
FR2738151B1 (fr) Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
BE1003071A5 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments.
FR2400037A1 (fr) Oligo-heteropolysaccharides a activite semblable a celle de l'heparine, procede pour leur preparation et compositions therapeutiques correspondantes
EP0769968A4 (fr) Vecteurs retroviraux produits par des lignees de cellules productrices resistantes a la lyse par le serum humain
GR3004988T3 (fr)
DE3881467D1 (de) Vasokonstriktor-peptid.
FR2567884B1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
BE902641A (fr) Dentifrice stable contenant de la dextranase.
SE8604991L (sv) Tillvexthemmande peptid fran ormgift
ATE172470T1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
FR2534273B1 (fr) Lignees cellulaires originaires de mammiferes superieurs, productrices d'hormone de croissance, de preference humaine, et vecteurs pour leur obtention
EP0344979A3 (fr) Antagonistes des récepteurs alpha-adrénergiques
EP0344980A3 (fr) Antagonistes des récepteurs alpha-adrénergiques
MA20926A1 (fr) Composes heterocycliques azotes nouveaux, compositions les contenant, leur preparation et leur application pour reduire la perte d'humidite de plantes et pour accroitre le rendement de cultures.
DE3781017D1 (de) Cytotoxische zusammensetzung aus "killer"-zellen.
TR199801251T2 (xx) Eritrosit olu�umunu te�vik i�in thieno (2,3-b) pyrazolo (3,4-D) pyridin-3-on'lar.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ONCOGEN SOC.EN COMMANDITE

Effective date: 19911130